Veracyte | VCYT - 流动资产

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.5B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	流动资产	更改		日
Agenus	USD 133.44M		514K	2025-12
Agilent	USD 4.62B		21M	2025-12
Anika Therapeutics	USD 103.36M		1.77M	2025-12
Arrowhead Research	USD 1.17B		223.75M	2025-12
Bruker	USD 2.21B		138.1M	2025-12
Exact Sciences	USD 1.56B		34.88M	2025-12
Heron Therapeutics	USD 238.07M		8.67M	2025-12
Illumina	USD 3.29B		493M	2025-12
Intrexon	USD 23.72M		45.04M	2024-06
Karyopharm Therapeutics	USD 89.75M		8.12M	2025-09
Laboratory Of America	USD 4.02B		58.3M	2025-12
Ligand Pharmaceuticals	USD 832.27M		78.35M	2025-12
Myriad Genetics	USD 332.6M		12.2M	2025-12
Rigel Pharmaceuticals	USD 214.93M		39.53M	2025-09
Roche Holding	CHF 38.73B		3.03B	2025-12
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
Siemens	EUR 67.91B		3.2B	2025-12
Sonic Healthcare	AUD 2.3B		52.76M	2024-12
Thermo Fisher Scientific	USD 28.71B		6.41B	2025-12
Veracyte	USD 488.38M		39.15M	2025-12
Waters	USD 1.99B		69.86M	2025-12